GoldBamboo.com - Knowledge is strong medicine
  

Combination Chemotherapy in Treating Patients With Stage I, II, or IIIA Non-small Cell Lung Cancer That Has Been Surgically Removed - Article


  Not Signed In - Sign In / Register


Get Your Free Credit Report Right Now!

Zip Code:






Small Businesses

 




Clinical Trial: Combination Chemotherapy in Treating Patients With Stage I, II, or IIIA Non-small Cell Lung Cancer That Has Been Surgically Removed

This study is no longer recruiting patients.

Sponsored by: European Institute of Oncology
Information provided by: National Cancer Institute (NCI)

Purpose

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells.

PURPOSE: Randomized phase III trial to compare cisplatin and etoposide with no chemotherapy in treating patients who have stage I, stage II, or stage IIIA non-small cell lung cancer that has been surgically removed.

Condition Treatment or Intervention Phase
stage I non-small cell lung cancer
stage II non-small cell lung cancer
stage IIIA non-small cell lung cancer
 Drug: cisplatin
 Drug: etoposide
 Procedure: adjuvant therapy
 Procedure: chemotherapy
Phase III

MedlinePlus related topics:  Lung Cancer

Study Type: Interventional
Study Design: Treatment

Official Title: Phase III Adjuvant Study of Cisplatin and Etoposide Combination for Stages I, II, and IIIA Non-Small Cell Lung Cancer

Further Study Details: 

OBJECTIVES:

OUTLINE: This a randomized study (treatment vs no treatment). Patients are stratified according to sex and to stage of disease (I vs II vs IIIA).

Patient receives cisplatin and etoposide on days 1-3, every 28 days, for 3 cycles. Patient may receive radiation therapy after surgery at the discretion of the physician.

PROJECTED ACCRUAL: Approximately 750 patients will be accrued over 3 years.

Eligibility

Ages Eligible for Study:  up to  70 Years,  Genders Eligible for Study:  Both

Criteria

DISEASE CHARACTERISTICS:

  • Histologically proven stage I, II, or IIIA non-small cell lung cancer after radical surgery
  • No evidence of lymphonodal enlargement during postsurgical chest CT scan

PATIENT CHARACTERISTICS: Age:

  • 70 and under

Performance status:

  • ECOG 0-2

Life expectancy:

  • Not specified

Hematopoietic:

  • WBC at least 3,500/mm3
  • Platelet count at least 100,000/mm3

Hepatic:

  • Not specified

Renal:

  • Creatinine no greater than 1.5 times the upper limit of normal

Pulmonary:

  • FEV1 at least 1 liter

Other:

PRIOR CONCURRENT THERAPY: Biologic therapy:

  • Not specified

Chemotherapy:

  • Not specified

Endocrine therapy:

  • Not specified

Radiotherapy:

  • Not specified

Surgery:


Location Information


Greece
      George Papanicolaou General Hospital, THESSALONIKI,  57010,  Greece

Italy
      ASL NO. 1 Imperiese, San Remo,  18038,  Italy

      Azienda Ospedaliera di Padova, Padova (Padua),  35128,  Italy

      Azienda Ospedaliera S. Maria, Terni,  05100,  Italy

      Azienda Ospedaliera, Reggio Emilia,  42100,  Italy

      Azienda Policlinico Umberto Primo, Rome,  00161,  Italy

      Azienda USSL No 4, Saronno,  21047,  Italy

      Azienda USSL NO 8, Merate,  22055,  Italy

      Carlo Poma Hospital, Mantova,  46100,  Italy

      Casa di Cura S. Maria, Varese,  21100,  Italy

      Casa Di Cura San Ambrogio, Milano,  20149,  Italy

      Cattedra di Immunologia Clinica, Turin (TO),  10128,  Italy

      Cattedra di Oncologia Medica - Universita degli Studi di Cagliari, Cagliari,  09124,  Italy

      Clinica Universita, Torino,  10126,  Italy

      Consorzio Mario Negri Sud, Santa Maria Imbaro,  66030,  Italy

      Consorzio Provinciale Antitubercolare, Milano,  20124,  Italy

      Dispensario Igiene Sociale, Toino,  10100,  Italy

      Federico II University Medical School, Naples (Napoli),  80131,  Italy

      Instituto Di Oncologia, Messina,  98122,  Italy

      Istituti Fisioterapici Ospitalieri - Roma, Rome,  00128,  Italy

      Istituto Clinica Medica, Sassari,  07100,  Italy

      Istituto Di Science Biomediche San Paolo, Milano,  20142,  Italy

      Istituto Nazionale per la Ricerca sul Cancro, Genoa (Genova),  16132,  Italy

      Istituto Nazionale per lo Studio e la Cura dei Tumori, Naples,  80131,  Italy

      Istituto Scientifico H.San Raffaele, Milano,  20132,  Italy

      Istituto Tumori/Fondazione Pascale, Naples (Napoli),  80131,  Italy

      Nuovo Ospedale San Gerardo, Monza,  20052,  Italy

      Ospedale Agnelli, Pinerolo,  10064,  Italy

      Ospedale Alessandro Manzoni, Lecco,  23900,  Italy

      Ospedale Bassini, Balsamo Cinisello,  20092,  Italy

      Ospedale C. Ascalesi, Napoli,  80139,  Italy

      Ospedale Carlo Forlanini, Rome,  00149,  Italy

      Ospedale Cattinara, Trieste,  Italy

      Ospedale Civico E Benefratelli, Palermo,  90127,  Italy

      Ospedale Civile Asilo Vittoria, Mortara,  27036,  Italy

      Ospedale Civile Cosenza, Cosenza,  87100,  Italy

      Ospedale Civile Feltre, Feltre,  32100,  Italy

      Ospedale Civile Negrar, Negrar,  37024,  Italy

      Ospedale Civile Rho, Rho,  20017,  Italy

      Ospedale Civile Umberto I, Mestre,  30174,  Italy

      Ospedale Di Conselice, Conselice,  48017,  Italy

      Ospedale Di Gorgonzola, Gorgonzola,  20064,  Italy

      Ospedale Di Predabissi Melegnano, Melegnano,  20077,  Italy

      Ospedale Galliera Oncologia, Genova (Genoa),  16128,  Italy

      Ospedale General Regional Ca Foncello, Treviso,  31100,  Italy

      Ospedale Generale Prov. Boldrini, Thiene,  36016,  Italy

      Ospedale Legnago USSL 21, Legnago,  37045,  Italy

      Ospedale Luigi Sacco, Milano (Milan),  20157,  Italy

      Ospedale Maggiore Ca'Granda, Milano (Milan),  20162,  Italy

      Ospedale Maggiore Crema, Crema,  26013,  Italy

      Ospedale Maggiore dell' Universita, Trieste,  34100,  Italy

      Ospedale Maggiore Lodi, Lodi,  I-20075,  Italy

      Ospedale Maggiore Parma, Parma,  43100,  Italy

      Ospedale Oncologico A. Businco, Cagliari,  09121,  Italy

      Ospedale S. Camillo-Forlanini, Rome,  00152,  Italy

      Ospedale S. Chiara, Trento,  38100,  Italy

      Ospedale San Bortolo, Vicenza,  36100,  Italy

      Ospedale San Carlo Borromeo, Milano (Milan),  20153,  Italy

      Ospedale San Filippo Neri, Rome,  00135,  Italy

      Ospedale San Giuseppe, Milano,  20100,  Italy

      Ospedale San Isidoro, Trescore Balneario,  24069,  Italy

      Ospedale San Martino/Cliniche Universitarie Convenzionate, Genoa (Genova),  16132,  Italy

      Ospedale San Michele, Cagliari,  09134,  Italy

      Ospedale Sant Anna, Como,  22100,  Italy

      Ospedale Santa Croce, Moncalieri,  10024,  Italy

      Ospedale Santa Croce, Cuneo,  12100,  Italy

      Ospedale Sesto San Giovanni, Sesto San Giovanni,  20099,  Italy

      Ospedale Silvestrini, Perugia,  06132,  Italy

      Ospedale Sta. Maria Delle Croci, Ravenna,  48100,  Italy

      Ospedale Torrette University Ancona, Parma,  43100,  Italy

      Ospedale Umberto I, Lugo DI Romagna,  48022,  Italy

      Ospedale Valduce, Como,  22100,  Italy

      Ospedale Vincenzo Monaldi, Napoli,  80131,  Italy

      Policlinico A. Gemelli - Universita Cattolica del Sacro Cuore, Rome,  00168,  Italy

      Policlinico di Careggi, Firenze (Florence),  50134,  Italy

      Policlinico Militare Celio, Rome,  00184,  Italy

      Spedali Civili, Brescia,  25124,  Italy

      U.S.L. 10 Villa Ognissanti, Firenze,  50139,  Italy

      U.S.S.L. 72 Magenta, Magenta,  20013,  Italy

      Universita Degli Studi di Bari Policlinico, Bari,  70124,  Italy

      Universita Degli Studi di Firenze - Policlin. di Careggi, Firenze (Florence),  1 (50134),  Italy

      Universita Degli Studi di Udine, Udine,  33100,  Italy

      Universita di Ferrara, Ferrara,  44100,  Italy

      Universita di Torino, Torino,  10126,  Italy

      University of Padua, Padua,  35128,  Italy

Korea, Republic of
      Inha University Hospital, Incheon,  Korea, Republic of

Study chairs or principal investigators

Antonio Nicolucci, MD,  Study Chair,  Consorzio Mario Negri Sud   

More Information

Clinical trial summary from the National Cancer Institute's PDQ® database

Study ID Numbers:  CDR0000065700; CNR-NICO-01; EU-97010
Record last reviewed:  February 2004
Last Updated:  October 13, 2004
Record first received:  November 1, 1999
ClinicalTrials.gov Identifier:  NCT00003053
Health Authority: Unspecified
ClinicalTrials.gov processed this record on 2005-04-08


Source: ClinicalTrials.gov
Cache Date: April 9, 2005

Resources



[ Disclaimer: The information on GoldBamboo for any particular treatment, medicine, drug, or herbal product might be missing or incomplete, and should never be used as a single source of knowledge. GoldBamboo generally has links to authoritative sites displayed toward the bottom of each topic page under the heading "Resources". ]

Take control over your directory listings...INSTANTLY

Every day, thousands of users find businesses like yours in the GoldBamboo directory.

Limited Time Offer!!!

For only $30 a year, a savings of 70% off our standard rate:

  • Edit your listing (whenever you want!)
  • Link to your website
  • Choose which categories you are listed in
  • Describe your services

The process will take only a few minutes and consists of 3 easy steps:

1. Register     >     2. Edit Listings     >     3. Publish

Your Company
your street
yourtown, YS 12345
888-888-8888



No Thanks

Popular Treatments

Acne Treatment ADHD Treatment Allergy Treatment Alzheimer's Treatment
Anemia Treatment Arthritis Treatment Asthma Treatment Bipolar Disorder Treatment
Bird Flu Treatment Bladder Cancer Treatment Bladder Control Treatment Blood Pressure Treatment
Brain Tumor Treatment Breast Cancer Treatment Bronchitis Treatment Cancer Treatment
Cancer Alternative Treatment Cataract Treatment Cirrhosis Treatment Colitis Treatment
Colon Cancer Treatment Common Cold Treatment Conjunctivitis Treatment Constipation Treatment
Crohn's Disease Treatment Cystic Fibrosis Treatment Depression Treatment Dermatitis Treatment
Diabetes Treatment Edema Treatment Epilepsy Treatment Erectile Dysfunction Treatment
Fibromyalgia Treatment GERD Treatment Glaucoma Treatment Gout Treatment
Hay Fever Treatment Headache Treatment Heart Disease Treatment Hepatitis Treatment
High Blood Pressure Treatment High Cholesterol Treatment Hives Treatment Hypertension Treatment
Hypoglycemia Treatment IBS Treatment Impotence Treatment Indigestion Treatment
Infertility Treatment Influenza Treatment Insomnia Treatment Lactose Intolerance Treatment
Leukemia Treatment Lung Cancer Treatment Lyme Disease Treatment Macular Degeneration Treatment
Menopause Treatment Migraine Treatment Osteoarthritis Treatment Osteoporosis Treatment
Pancreatic Cancer Treatment PMS Treatment Pneumonia Treatment Prostate Diseases Treatment
Restless Leg Treatment Rheumatoid Arthritis Treatment Sepsis Treatment Sinusitis Treatment
Skin Cancer Treatment Sleep Apnea Treatment Snoring Treatment Stroke Treatment
Testicular Cancer Treatment
GoldBambooTM

Your Integrative Health and Wellness Resource for Small Businesses.

December 4, 2009



Page Updated: November 22, 2004
============== Advertisement ==============
Disclaimer: All material displayed on the GoldBamboo.com website is provided for educational purposes only. Consult a physician regarding the applicability of any information found on GoldBamboo.com to your symptoms or medical condition.

Home | About Us | Link To Us | Feedback | Disclaimer | Privacy Policy | Terms of Use | Health Forums

Copyright © 2004-2009 - Anaconda Partners LLC - All rights reserved.

HONcode accreditation seal.

We comply with the HONcode standard for health trust worthy information:
verify here.